Key facts
- Galileo (Clinics/Outpatient Services)’s last known valuation is $361.5M (Jun 2025).
- It has raised $209.9M across 1 recorded rounds; the latest was Later Stage VC (Series D) ($60.0M) in Dec 2022.
- Notable investors include Gaingels, GV, 8VC, Lux Capital, Redpoint Ventures — 27 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Galileo (Clinics/Outpatient Services)
Funding rounds
1 roundsAbout Galileo (Clinics/Outpatient Services)
Developer of a health assistance mobile application designed to make healthcare more effective and affordable. The company's application combines technology with human-centered design, and it offers lab monitoring with specialty medications, enabling users to have access to a team of expert clinicians wherever they might be to stay fit.
- Industry
- Clinics/Outpatient Services
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2016
- Employees
- 471
- Website
- galileo.io/
- Ownership
- Privately Held (backing)
Galileo (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Galileo (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Galileo (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.